Please Wait.....
Report
Canine Atopic Dermatitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others), By Mode of Administration (Topical, Oral, Injectable), By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce), By Region & Competition, 2020-2030F
Market Report I 2025-03-24 I 185 Pages I TechSci Research
The global Canine Atopic Dermatitis Market was valued at USD 995.60 million in 2024 and is projected to experience robust growth, with a compound annual growth rate (CAGR) of 9.90% from 2024 to 2030. This market encompasses products and services related to the diagnosis, treatment, and management of atopic dermatitis in dogs-a common skin condition that causes itching, inflammation, and discomfort. The market includes various therapies and treatments aimed at alleviating symptoms and improving the quality of life for affected dogs. According to recent data from the Pet Food Manufacturers' Association (PFMA), the United Kingdom was expected to have 34.9 million pets in 2022, including 13 million dogs. This rising pet population underscores the increasing demand for advanced veterinary care, which has driven the specialization of veterinary professionals in dermatological conditions, highlighting the growing focus on comprehensive pet healthcare services.
Key Market Drivers:
Rising Pet Ownership and Humanization: The global pet industry has seen significant growth, largely due to an increasing number of pet owners worldwide. Along with this trend, pets are increasingly being regarded as family members rather than just companions, a shift that has major implications for various pet-related markets, including the canine atopic dermatitis market. The 2021-2022 American Pet Products Association (APPA) National Pet Owners Survey revealed that dog owners spent an average of USD 458 on surgical veterinary visits and USD 242 on routine visits. This growing investment in pet health, combined with increasing awareness of canine health issues, is driving demand for advanced treatments, including those for conditions such as canine allergic dermatitis, thereby fostering growth in the veterinary care market. In particular, the rise in pet ownership has led to increased demand for healthcare products and services, including treatments for chronic conditions like atopic dermatitis. As pets are increasingly seen as family members, pet owners are more likely to prioritize high-quality healthcare, including preventive measures and ongoing management of conditions such as canine atopic dermatitis.
Key Market Challenges:
Misdiagnosis and Underdiagnosis: A key challenge in managing canine atopic dermatitis is the potential for misdiagnosis or underdiagnosis. Symptoms such as itching, redness, and skin irritation often overlap with other skin conditions, making accurate diagnosis essential. Failing to identify atopic dermatitis can result in improper treatments or a lack of intervention, potentially worsening the dog's condition.
Varied Triggers: Canine atopic dermatitis has various triggers, including environmental allergens, food sensitivities, and genetic factors. Identifying the specific trigger for each dog can be challenging, which makes developing a universal treatment plan difficult. This variability requires a personalized approach to treatment and care.
Compliance and Duration of Treatment: Ensuring compliance with prescribed treatment regimens over the long term can be a challenge for both pet owners and veterinarians. The ongoing nature of the condition necessitates sustained management, which may impact adherence to prescribed therapies.
Key Market Trends:
Advancements in Immunotherapy: Allergen-specific immunotherapy (ASIT) is becoming more refined and accessible. The development of more accurate allergy testing methods and innovative ASIT treatments is expected to enhance the management of atopic dermatitis by targeting the specific allergens that cause the condition in each dog.
Targeted Therapies: Pharmaceutical advancements are leading to the development of targeted therapies that address the underlying causes of canine atopic dermatitis. These treatments aim to reduce the need for long-term symptom management, ultimately improving the quality of life for affected dogs.
Holistic and Alternative Therapies: Holistic and alternative treatments, such as acupuncture, herbal remedies, and physical rehabilitation, are gaining popularity as complementary options for managing atopic dermatitis. These approaches are being recognized for their potential to improve overall well-being and provide additional management options for pet owners seeking non-traditional therapies.
Key Market Players:
- Zoetis Inc.
- Elanco Animal Health Inc.
- Virbac SA
- Toray Industries Inc.
- AB Science SA
- Boehringer Ingelheim GmbH
- Kindred Biosciences Inc.
Report Scope:
This report segments the global Canine Atopic Dermatitis Market into multiple categories, providing valuable insights into industry trends and forecasts. The market is segmented as follows:
- By Product:
o Glucocorticoids
o Antihistamines
o Immunosuppressants
o Monoclonal Antibodies (MAbs)
o Others
- By Mode of Administration:
o Topical
o Oral
o Injectable
- By Distribution Channel:
o Veterinary Hospitals/Clinics
o Retail
o E-commerce
- By Region:
o North America: United States, Canada, Mexico
o Europe: Germany, United Kingdom, France, Italy, Spain
o Asia-Pacific: China, Japan, India, Australia, South Korea
o South America: Brazil, Argentina, Colombia
o Middle East & Africa: South Africa, Saudi Arabia, UAE, Kuwait
Competitive Landscape:
This section offers a detailed analysis of the major players operating in the global Canine Atopic Dermatitis Market.
Available Customizations:
TechSci Research provides customization options for this market report based on specific company requirements. Customization options include detailed profiles of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Canine Atopic Dermatitis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
5.2.2. By Mode of Administration (Topical, Oral, Injectable)
5.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Mode of Administration
5.3.3. By Distribution Channel
5.3.4. By Region
6. North America Canine Atopic Dermatitis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
6.2.2. By Mode of Administration (Topical, Oral, Injectable)
6.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Canine Atopic Dermatitis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Mode of Administration
6.3.1.2.3. By Distribution Channel
6.3.2. Canada Canine Atopic Dermatitis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Mode of Administration
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico Canine Atopic Dermatitis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Mode of Administration
6.3.3.2.3. By Distribution Channel
7. Europe Canine Atopic Dermatitis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
7.2.2. By Mode of Administration (Topical, Oral, Injectable)
7.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Canine Atopic Dermatitis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Mode of Administration
7.3.1.2.3. By Distribution Channel
7.3.2. United Kingdom Canine Atopic Dermatitis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Mode of Administration
7.3.2.2.3. By Distribution Channel
7.3.3. France Canine Atopic Dermatitis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Mode of Administration
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Canine Atopic Dermatitis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Mode of Administration
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Canine Atopic Dermatitis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Mode of Administration
7.3.5.2.3. By Distribution Channel
8. Asia-Pacific Canine Atopic Dermatitis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
8.2.2. By Mode of Administration (Topical, Oral, Injectable)
8.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Canine Atopic Dermatitis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Mode of Administration
8.3.1.2.3. By Distribution Channel
8.3.2. Japan Canine Atopic Dermatitis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Mode of Administration
8.3.2.2.3. By Distribution Channel
8.3.3. India Canine Atopic Dermatitis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Mode of Administration
8.3.3.2.3. By Distribution Channel
8.3.4. Australia Canine Atopic Dermatitis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Mode of Administration
8.3.4.2.3. By Distribution Channel
8.3.5. South Korea Canine Atopic Dermatitis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Mode of Administration
8.3.5.2.3. By Distribution Channel
9. South America Canine Atopic Dermatitis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
9.2.2. By Mode of Administration (Topical, Oral, Injectable)
9.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Canine Atopic Dermatitis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Mode of Administration
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina Canine Atopic Dermatitis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Mode of Administration
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia Canine Atopic Dermatitis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Mode of Administration
9.3.3.2.3. By Distribution Channel
10. Middle East and Africa Canine Atopic Dermatitis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
10.2.2. By Mode of Administration (Topical, Oral, Injectable)
10.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Canine Atopic Dermatitis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Mode of Administration
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia Canine Atopic Dermatitis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Mode of Administration
10.3.2.2.3. By Distribution Channel
10.3.3. UAE Canine Atopic Dermatitis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Mode of Administration
10.3.3.2.3. By Distribution Channel
10.3.4. Kuwait Canine Atopic Dermatitis Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Mode of Administration
10.3.4.2.3. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Zoetis Inc
14.2. Elanco Animal Health Inc
14.3. Virbac SA
14.4. Toray Industries Inc
14.5. AB Science SA
14.6. Boehringer Ingelheim GmbH
14.7. Kindred Biosciences Inc
15. Strategic Recommendations
16. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security